Asia Pacific Drug Modelling Software Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By roduct Type (Database, Software, and Others); Application (Drug Discovery and Development, Computational Physiological Medicine, Disease Modelling, Medical Imaging, Predictive Analysis of Drug Targets, Simulation Software, Cellular Simulation, and Others), and Country
Market Introduction
Drug modelling has become an essential tool in the drug design process. Software based drug discovery and development methods are playing key role in the development of novel drugs. Software based methods such as molecular modelling, structure-based drug design, structure-based virtual screening, ligand interaction and molecular dynamics are considered to be powerful tool for investigation of pharmacokinetic and pharmacodynamic properties of drugs. These methods are fast, accurate, and provide valuable insights of experimental findings and mechanisms of action. In addition, appropriate implementation of these techniques may help in reducing cost of drug designing and development.
Get more information on this report :
Market Overview and Dynamics
The Asia Pacific drug modelling software market is expected to reach US$ 2,401.22 million by 2027 from US$ 1,252.66 million in 2019. The market is anticipated to grow at a CAGR of 8.8% during 2019–2027. The increasing adoption of in-silico modelling tools in drug discovery, and increasing economic burden of drug discovery are the major factors expected to boost the growth of the drug modelling software market in Asia Pacific. However, the market is likely to get impacted by the risk factor such as less adoption in emerging countries during the forecast period.
Key Market Segments
In terms of product type, the software segment accounted for the largest share of the Asia Pacific drug modelling software market in 2019. In terms of application, drug discovery and development segment accounted for the largest share of the Asia Pacific drug modelling software market in 2019.
Major Sources and Companies Listed
Several major primary and secondary sources associated with the Asia Pacific drug modelling software market report are the India Brand Equity Foundation (IBEF), World Health Organization (WHO), Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), and others.
Reasons to buy report
- It provides understanding of the Asia Pacific, drug modelling software market landscape and identifies drug modelling software market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Asia Pacific drug modelling software market.
- It helps efficiently plan merger and acquisition, and partnership deals in the drug modelling software market by identifying market segments with the most promising probable sales
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of drug modelling software market performance of various segments pertaining to the Asia Pacific drug modelling software market.
- It provides drug modelling software market revenue forecast of the market based on various segments for the period from 2019 to 2027.
ASIA PACIFIC DRUG MODELLING SOFTWARE MARKET SEGMENTATION
By Product Type
- Database
- Software
- Others
By Application
- Drug Discovery and Development
- Computational Physiological Medicine
- Disease Modeling
- Medical Imaging
- Predictive Analysis of Drug Targets
- Simulation Software
- Cellular Simulation
- Others
By Country
- India
- China
- Japan
- South Korea
- Australia
Company Profiles
- Crown Bioscience Inc (JSR life science)
- Genedata AG
- Biognos AB
- Dassault Systèmes
- Acellera
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Drug Modelling Software Market – By Product Type
1.3.2 Asia Pacific Drug Modelling Software Market – By Application
1.3.3 Asia Pacific Drug Modelling Software Market – By Country
2. Asia Pacific Drug Modelling Software Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Drug Modelling Software Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Drug Modelling Software Market - Asia Pacific PEST Analysis
4.3 Expert Opinion
5. Asia Pacific Drug Modelling Software Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Adoption of Modelling Tools in Drug Discovery
5.1.2 Increasing Economic Burden of Drug Discovery
5.2 Key Market Restraints
5.2.1 Less Adoption in Emerging Countries
5.3 Key Market Opportunities
5.3.1 Strategic Activities by Market Players
5.4 Future Trends
5.4.1 Growing Adoption of Artificial Intelligence in Drug Discovery
5.5 Impact analysis
6. Drug Modelling Software Market – Asia Pacific Analysis
6.1 Asia Pacific Drug Modelling Software Market Revenue Forecasts and Analysis
7. Asia Pacific Drug Modelling Software Market Analysis and Forecasts To 2027 – By Product Type
7.1 Overview
7.2 Asia Pacific Drug Modelling Software Market, By Product Type 2019 & 2027 (%)
7.2.1 Asia Pacific Drug Modelling Software Market Revenue and Forecasts to 2027, By Product Type (US$ Mn)
7.3 Database
7.3.1 Overview
7.3.2 Asia Pacific Database Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Software
7.4.1 Overview
7.4.1.1 Asia Pacific Software Revenue and Forecasts to 2027 (US$ Mn)
7.5 Other Product Types
7.5.1 Overview
7.5.2 Asia Pacific Other Product Types Market Revenue and Forecast to 2027 (US$ Mn)
8. Asia Pacific Drug Modelling Software Market Analysis and Forecasts To 2027 – By Application
8.1 Overview
8.2 Asia Pacific Drug Modelling Software Market, By Application 2019 & 2027 (%)
8.2.1 Asia Pacific Drug Modelling Software Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Drug Discovery and Development
8.3.1 Overview
8.3.2 Asia Pacific Drug Discovery and Development Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Computational Physiological Medicine
8.4.1 Overview
8.4.2 Asia Pacific Computational Physiological Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Disease Modelling
8.5.1 Overview
8.5.2 Asia Pacific Disease Modelling Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Medical Imaging
8.6.1 Overview
8.6.2 Asia Pacific Medical Imaging Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Predictive Analysis of Drug Targets
8.7.1 Overview
8.7.2 Asia Pacific Predictive Analysis of Drug Targets Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Simulation Software
8.8.1 Overview
8.8.2 Asia Pacific Simulation Software Market Revenue and Forecasts to 2027 (US$ Mn)
8.9 Cellular Simulation
8.9.1 Overview
8.9.2 Asia Pacific Cellular Simulation Market Revenue and Forecasts to 2027 (US$ Mn)
8.10 Others
8.10.1 Overview
8.10.2 Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. Drug Modelling Software Market Revenue and Forecasts To 2027 – Geographical Analysis
9.1 Asia Pacific Drug modelling software Market Revenue and Forecasts To 2027
9.1.1 Overview
9.1.2 Asia-Pacific: Drug Modelling Software Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 Asia-Pacific Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
9.1.4 Asia-Pacific Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
9.1.5 Asia-Pacific: Drug Modelling Software Market, by Country, 2019 & 2027 (%)
9.1.1 China: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.1.1 China: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.1.2 China Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
9.1.1.3 China Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
9.1.2 Japan: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.2.1 Japan: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.2.2 Japan Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
9.1.2.3 Japan Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
9.1.3 India: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.3.1 India: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.3.2 India Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
9.1.3.3 India Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
9.1.4 South Korea: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.4.1 South Korea: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.4.2 South Korea Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
9.1.4.3 South Korea Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
9.1.5 Australia: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.1 Australia: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.2 Australia Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
9.1.5.3 Australia Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
10. Impact of COVID-19 Pandemic on Asia Pacific Drug Modelling Software Market
10.1 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11. Company Profiles
11.1 Genedata AG
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Biognos AB
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Dassault Systèmes
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Acellera
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.5 Crown Bioscience Inc (JSR life science)
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
12. Appendix
12.1 About the Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Drug Modelling Software Market Revenue and Forecasts To 2027, By Product Type (US$ Mn)
Table 2. Asia Pacific Drug Modelling Software Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. Asia-Pacific Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 4. Asia-Pacific Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 5. China Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 6. China Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 7. Japan Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 8. Japan Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 9. India Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 10. India Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 11. South Korea Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 12. South Korea Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 13. Australia Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)
Table 14. Australia Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 15. Glossary of Terms, Drug Modelling Software Market
LIST OF FIGURES
Figure 1. Drug Modelling Software Market Segmentation
Figure 2. Asia Pacific Drug Modelling Software Market Overview
Figure 3. Software Segment Held Largest Share of Drug Modelling Software Market
Figure 4. India is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Asia Pacific Drug Modelling Software Market - Leading Country Markets (US$ Mn)
Figure 6. Drug Modelling Software Market - Asia Pacific PEST Analysis
Figure 7. Drug Modelling Software Market Impact Analysis of Driver and Restraints
Figure 8. Asia Pacific Drug Modelling Software Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. Asia Pacific Drug Modelling Software Market, By Product Type 2019 & 2027 (%)
Figure 10. Asia Pacific Database Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Asia Pacific Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Asia Pacific Other Product Types Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. Asia Pacific Drug Modelling Software Market, By Application 2019 & 2027 (%)
Figure 14. Asia Pacific Drug Discovery and Development Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Asia Pacific Computational Physiological Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Asia Pacific Disease Modelling Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. Asia Pacific Medical Imaging Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Asia Pacific Predictive Analysis of Drug Targets Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Asia Pacific Simulation Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Asia Pacific Cellular Simulation Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Asia Pacific Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. Asia-Pacific: Drug Modelling Software Market, by Key Country– Revenue (2019) (USD Million)
Figure 23. Asia-Pacific Drug Modelling Software Market Revenue and Forecast to 2027 (USD Million)
Figure 24. Asia-Pacific: Drug Modelling Software Market, by Country, 2019 & 2027 (%)
Figure 25. China: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
Figure 26. Japan: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. India: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. South Korea: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. Australia: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
The List of Companies - Asia Pacific Drug Modelling Software Market
- Crown Bioscience Inc (JSR life science)
- Genedata AG
- Biognos AB
- Dassault Systèmes
- Acellera
- It provides understanding of the Asia Pacific, drug modelling software market landscape and identifies drug modelling software market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Asia Pacific drug modelling software market.
- It helps efficiently plan merger and acquisition, and partnership deals in the drug modelling software market by identifying market segments with the most promising probable sales.
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of drug modelling software market performance of various segments pertaining to the Asia Pacific drug modelling software market.
- It provides drug modelling software market revenue forecast of the market based on various segments for the period from 2019 to 2027.